How to Determine Glycan Profiles of Biopharmaceuticals from Peptide Mapping Data

Applications | 2021 | BrukerInstrumentation
Ion Mobility, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Industries
Pharma & Biopharma
Manufacturer
Bruker
Downloadable PDF for viewing
 

Similar PDF

Glycopeptide Characterization for Various Monoclonal Antibodies Using the Agilent 6545XT AdvanceBio LC/Q-TOF
Glycan Analysis - Agilent BioHPLC Columns Application Compendium
Agilent BioHPLC Columns - Characterization of NIST Monoclonal Antibody Critical Quality Attributes - Application Compendium
In Depth Analysis of Host Cell Proteins from Antibody Preparations using PASEF